Related Experiment Videos
Repeated hepatic resections for colorectal metastases
C Gouillat1, C Ducerf, C Partensky
1University Department of Surgery, Hôtel Dieu, Lyon, France.
Summary
Repeated hepatic resection (RHR) for recurrent colorectal metastases is feasible and safe in experienced centers. However, the overall oncologic benefit of RHR remains questionable despite aggressive management.
Area of Science:
- Hepatobiliary Surgery
- Surgical Oncology
- Colorectal Cancer Metastasis
Background:
- Repeated hepatic resection (RHR) for recurrent colorectal metastases is uncommon and controversial.
- Assessing the feasibility and oncologic benefit of aggressive management is crucial.
Purpose of the Study:
- To evaluate the feasibility and potential oncologic benefit of repeated hepatic resection (RHR) for recurrent colorectal metastases.
Main Methods:
- Retrospective review of 13 patients who underwent RHR between 1981 and 1991.
- Analysis of patient data including type of resection, delay between procedures, and survival outcomes.
Main Results:
- No post-operative mortality was observed.
- Median survival after the second hepatic resection was 17 months, and 31 months after the first.
- One patient remained recurrence-free at 84 months post-first hepatectomy.
Conclusions:
- RHR is feasible and safe, even after major primary hepatectomy, within a well-trained surgical team.
- The oncologic benefit of RHR for recurrent colorectal metastases remains questionable.